Tauriga Sciences, Inc. and Mr.
Checkout Distributors Sign Distribution Agreement to Launch
Tauri-Gum Nationwide to as Many as 200,000 Retail Stores &
Locations
This Launch of Tauri-Gum™
will be Supported by a National Network of More than 1,100
Independent Direct Store Delivery (“DSD”)
Distributors
NEW YORK, NY -- July 6, 2020 -- InvestorsHub NewsWire -- Tauriga
Sciences, Inc. (OTCQB: TAUG)
(“Tauriga” or the “Company”), a revenue generating, diversified
life sciences company, with a proprietary line of functional
“supplement” chewing gums (Flavors: Pomegranate, Blood Orange,
Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two
ongoing Biotechnology initiatives, today announced that it has
entered into a Go-To-Market Distribution Agreement (the
“Agreement”) with Oviedo, Florida based Mr. Checkout Distributors
(“Mr. Checkout”). This Agreement (mutually executed on June 29,
2020) enables the Company to launch its flagship brand Tauri-Gum™,
on a National level, through Mr. Checkout’s network of Independent
DSD Distributors that service approximately 200,000 stores and
retail locations across the United States. These stores include
some of the most well-known convenience stores, gas station marts,
and supermarket chains. Mr. Checkout has also provided the Company
with inventory funding options, in anticipation of potential large
sales volume.
The Tauri-Gum™ Brand is Comprised of: 6 distinct “functional”
chewing gum flavors/versions: [3] CBD Isolate Infused (Pomegranate,
Blood Orange, Mint), [2] CBG Isolate Infused (Peach-Lemon, Black
Currant), and [1] Immune Booster / Vitamin C & Zinc Infused
(Pear Bellini). CBD = Cannabidiol / CBG =
Cannabigerol
Link - Corporate Website, Mr. Checkout
Distributors: https://mrcheckout.net/retail-channel-partners/
Tauriga’s CEO Seth M. Shaw expressed, “The Company is excited to
have this opportunity to launch its flagship Tauri-Gum™ brand on a
national level, with the preeminent DSD Distributor in the United
States. This is an important puzzle piece, with respect to
the Company’s strategy to build Tauri-Gum™ into a major national
brand. The Company is targeting the month of September 2020,
to commence this National product launch.
Joel Goldstein, CEO of Mr. Checkout Distributors, stated, “After
an extensive period of review, we decided to move forward with and
include the Tauri-Gum™ product line as part of our product
offerings. We were particularly impressed with the quality,
taste, diversity, and packaging of this exciting new brand.
We look forward to working with Tauriga Sciences, Inc. to make
Tauri-Gum™ available to customers across the Country.
ABOUT TAURIGA SCIENCES, INC.
Tauriga Sciences, Inc. (TAUG)
is a revenue generating, diversified life sciences company, engaged
in several major business activities and initiatives. The
company manufactures and distributes several proprietary retail
products and product lines, mainly focused on the Cannabidiol
(“CBD”) and Cannabigerol (“CBG”) Edibles market segment. The
main product line, branded as Tauri-Gum™, consists of a proprietary
supplement chewing gum that is both Kosher certified and Vegan
formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange,
Pomegranate) & (CBG Infused Tauri-Gum™ Flavor:
Peach-Lemon). The Company’s commercialization strategy
consists of a broad array of retail customers, distributors, and a
fast-growing E-Commerce business segment (E-Commerce
website: www.taurigum.com). Please visit our
corporate website, for additional information, as well as
inquiries, at www.tauriga.com.
Complementary to the Company’s retail business, are its two
ongoing biotechnology initiatives. The first one relates to
the development of a Pharmaceutical grade version of Tauri-Gum™,
for nausea regulation (specifically designed to help patients that
are subjected to ongoing chemotherapy treatment). On March
18, 2020, the Company announced that it filed a provisional U.S.
patent application covering its pharmaceutical grade version of
Tauri-Gum™. The Patent, filed with the U.S.P.T.O. is Titled
“MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS
OF TREATMENT”. The second one relates to a collaboration
agreement with Aegea Biotechnologies Inc. for the co-development of
a rapid, multiplexed, Novel Coronavirus (COVID-19) test with
superior sensitivity and selectivity.
The Company is headquartered in New York City and operates a
regional office in Barcelona, Spain. In addition, the Company
operates a full-time E-Commerce fulfillment center located in
LaGrangeville, New York.
ABOUT MR. CHECKOUT DISTRIBUTORS
Established 1989
| Mr. Checkout is
a national group of Independent
DSD Distributors, Full-Line
Grocery Distributors and Wagon-Jobbers.
We represent products in over 60
major retailers and manage 13 industry
associations with over 150,000 independent retail
members. Distributors, Wholesalers,
and Retailers turn to Mr. Checkout
to find the best-selling products, learn which categories are
trending and discover what is the next hot new product.
Please visit the following website: https://mrcheckout.net/dsd-distribution/
DISCLAIMER -- Forward-Looking Statements
This press release contains certain “forward-looking statements”
as defined by the Private Securities Litigation Reform Act of 1995
which represent management’s beliefs and assumptions concerning
future events. These forward-looking statements are often indicated
by using words such as “may,” “will,” “expects,” “anticipates,”
believes, “hopes,” “believes,” or plans, and may include statements
regarding corporate objectives as well as the attainment of certain
corporate goals and milestones. Forward-looking statements are
based on present circumstances and on management’s present beliefs
with respect to events that have not occurred, that may not occur,
or that may occur with different consequences or timing than those
now assumed or anticipated. Actual results may differ materially
from those expressed in forward-looking statements due to
known and unknown risks and uncertainties, such as are not
guarantees of general economic and business conditions, the ability
to successfully develop and market products, consumer and business
consumption habits, the ability to consummate successful
acquisition and licensing transactions, fluctuations in exchange
rates, and other factors over which Tauriga has little or no
control. Many of these risks and uncertainties are discussed in
greater detail in the “Risk Factors” section of Tauriga’s Form 10-K
and other filings made from time to time with the Securities and
Exchange Commission. Such forward-looking statements are made only
as of the date of this release, and Tauriga assumes no obligation
to update forward-looking statements to reflect subsequent events
or circumstances. You should not place undue reliance on these
forward-looking statements.
CONTACT INFORMATION
Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY 10022
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
Cell # (917) 796 9926
Instagram: @taurigum
Twitter: @SethMShaw
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Apr 2023 to Apr 2024